Sonoma Pharmaceuticals (SNOA) Interest Expenses (2010 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Interest Expenses of -$4000.0 for Q1 2026, down 233.33% year-over-year from $3000.0 in Q1 2025, and down 133.33% quarter-over-quarter from $12000.0 in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Interest Expenses (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Interest Expenses history runs 17 years deep, the most recent figure standing at -$4000.0 for Q1 2026.
- In Q1 2026, Interest Expenses fell 233.33% year-over-year to -$4000.0; the TTM figure through Mar 2026 stood at $6000.0 (down 60.0% YoY), while the FY2026 annual figure was $26.6 million, down 8.64% from the prior year.
- Interest Expenses for Q1 2026 stood at -$4000.0, down from $12000.0 in the prior quarter.
- The five-year high for Interest Expenses was $536000.0 in Q2 2022, with the low at -$4000.0 in Q1 2026.
- The 5-year median for Interest Expenses is $38000.0 (2023), against an average of $139937.5.
- The sharpest annual moves came in 2022 and 2026: Interest Expenses jumped 3714.29% in 2022, then plunged 233.33% in 2026.
- Sonoma Pharmaceuticals' Interest Expenses stood at $534000.0 in 2022, then plunged by 93.63% to $34000.0 in 2023, then soared by 420.59% to $177000.0 in 2024, then sank by 93.22% to $12000.0 in 2025, then sank by 133.33% to -$4000.0 in 2026.
- Business Quant data shows SNOA's Interest Expenses at -$4000.0 in Q1 2026, $12000.0 in Q4 2025, and $130000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 727,000.00 |
| Jun 30, 2026 | 727,000.00 |
| Mar 31, 2026 | -4,000.00 |
| Mar 31, 2026 | -4,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Sep 30, 2025 | 130,000.00 |
| Sep 30, 2025 | 130,000.00 |
| Jun 30, 2025 | 201,000.00 |
| Jun 30, 2025 | 201,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Sep 30, 2024 | 177,000.00 |
| Sep 30, 2024 | 177,000.00 |
| Jun 30, 2024 | 24,000.00 |
| Jun 30, 2024 | 24,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Dec 31, 2023 | 34,000.00 |
| Dec 31, 2023 | 34,000.00 |